News & Insights
It’s time to bridge the gap with Avec® and experience discovery at unprecedented speeds.
As CMO, Dr. Embi works across the organization to ensure our technologies address the driving issues and challenges of both researchers and physicians.
"We’re providing physicians and researchers the ability to view, analyze and experiment with aggregated data from disparate sources on a global scale. If there’s any way that we can improve on that process, and increase our clients’ speed of discovery, we are going to do it," said CEO John Raden.
Avec® securely connects disparate clinical trial and health data among clinical research networks—accelerating discover
In the fourth video in our series we talk about what drives our work each day: the human impact of Avec®. In the HIT industry, it’s easy to hone in on the large amounts of disparate data in need of integration and lose sight of its origin. But at Signet Accel, true interoperability is about more than code. Every piece of data represents a friend, loved one, family member or a colleague in need of or receiving care.
Avec® creators Dr. Philip Payne and Dr. Peter Embi discuss true interoperability in the second video of our four-part series exploring precision medicine, our unique approach to solving the interoperability problem, and the human impact of Avec®.